PFE, MRNA, JNJ, AZN: Big Pharma Stocks Staying Defensive, Trading Better

Published: June 14, 2022, 9:34 p.m.

b'Large cap pharmas continue to be defensive and are trading better than other stocks today, says Marshall Gordon. He discusses investing in the healthcare sector, highlighting the Health Care Select Sector SPDR Fund (XLV) which hit a 52-week low today. He also talks about his stock to watch, Pfizer (PFE) which he compares to other Covid-19 vaccine stocks such as Moderna (MRNA), Johnson & Johnson (JNJ), and AstraZeneca (AZN). Tune in to find out more.'